Tower Research Capital LLC (TRC) - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 1 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,641
+2.7%
6,760
+37.9%
0.00%
Q2 2023$12,304
+34077.8%
4,902
-76.5%
0.00%
-100.0%
Q1 2023$36
-68.7%
20,874
-22.9%
0.00%
-80.0%
Q4 2022$115
-99.2%
27,080
+137.7%
0.01%
Q3 2022$14,000
+55.6%
11,391
+21.7%
0.00%
Q2 2022$9,000
-10.0%
9,363
+124.2%
0.00%
Q1 2022$10,000
-9.1%
4,176
+2.3%
0.00%
Q4 2021$11,000
-8.3%
4,081
+73.0%
0.00%
Q3 2021$12,000
-53.8%
2,359
-31.3%
0.00%
-100.0%
Q2 2021$26,000
-7.1%
3,436
-28.7%
0.00%
Q1 2021$28,000
+55.6%
4,817
+27.3%
0.00%
-100.0%
Q4 2020$18,0003,7830.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Polar Capital Holdings Plc 6,961,913$51,936,0000.23%
LEVIN CAPITAL STRATEGIES, L.P. 38,762$289,0000.03%
Riverview Trust Co 1,000$7,0000.01%
HoyleCohen, LLC 10,432$78,0000.01%
Baillie Gifford 436,512$3,256,0000.00%
Tower Research Capital LLC (TRC) 3,436$26,0000.00%
Renaissance Technologies 125,452$936,0000.00%
ProShare Advisors LLC 23,304$174,0000.00%
Bradley & Co. Private Wealth Management, LLC 200$1,0000.00%
FIL Ltd 104,100$777,0000.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders